Real-time enrollment status for this t-cell lymphoma clinical trial
Current Status
Recruiting
Checked: March 2, 2026 at 8:48 AM UTC
| NCT Number | NCT06534060 |
| Recruiting Status | Recruiting |
| Condition | T-cell Lymphoma |
| Phase | Clinical Trial |
| Target Enrollment | 46 participants |
| Active Locations | 12 sites in the US |
| Sponsor | March Biosciences Inc |
| Last Updated on CT.gov | October 3, 2025 (Oct 3, 2025) |
As of March 2, 2026: Clinical trial NCT06534060 is currently recruiting participants. This clinical trial study for t-cell lymphoma is actively seeking new participants at 12 locations across the United States. The study is sponsored by March Biosciences Inc. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06534060 is actively recruiting participants as of March 2, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 12 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06534060 was last updated Oct 3, 2025 (October 3, 2025). HelloStudys verifies this status automatically.